AC Portal
Variant: 1   Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
Procedure Appropriateness Category Relative Radiation Level
CT head without IV contrast Usually Appropriate ☢☢☢
CTA head with IV contrast May Be Appropriate ☢☢☢
Arteriography cervicocerebral Usually Not Appropriate ☢☢☢
MRA head with IV contrast Usually Not Appropriate O
MRA head without and with IV contrast Usually Not Appropriate O
MRA head without IV contrast Usually Not Appropriate O
MRI head with IV contrast Usually Not Appropriate O
MRI head without and with IV contrast Usually Not Appropriate O
MRI head without IV contrast Usually Not Appropriate O
MRV head with IV contrast Usually Not Appropriate O
MRV head without and with IV contrast Usually Not Appropriate O
MRV head without IV contrast Usually Not Appropriate O
CT head with IV contrast Usually Not Appropriate ☢☢☢
CT head without and with IV contrast Usually Not Appropriate ☢☢☢
CTV head with IV contrast Usually Not Appropriate ☢☢☢

Variant: 2   Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
Procedure Appropriateness Category Relative Radiation Level
Arteriography cervicocerebral Usually Not Appropriate ☢☢☢
MRA head with IV contrast Usually Not Appropriate O
MRA head without and with IV contrast Usually Not Appropriate O
MRA head without IV contrast Usually Not Appropriate O
MRI head with IV contrast Usually Not Appropriate O
MRI head without and with IV contrast Usually Not Appropriate O
MRI head without IV contrast Usually Not Appropriate O
MRV head with IV contrast Usually Not Appropriate O
MRV head without and with IV contrast Usually Not Appropriate O
MRV head without IV contrast Usually Not Appropriate O
CT head with IV contrast Usually Not Appropriate ☢☢☢
CT head without and with IV contrast Usually Not Appropriate ☢☢☢
CT head without IV contrast Usually Not Appropriate ☢☢☢
CTA head with IV contrast Usually Not Appropriate ☢☢☢
CTV head with IV contrast Usually Not Appropriate ☢☢☢

Variant: 3   Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
Procedure Appropriateness Category Relative Radiation Level
MRI head without and with IV contrast Usually Appropriate O
MRI head without IV contrast May Be Appropriate O
Arteriography cervicocerebral Usually Not Appropriate ☢☢☢
MRA head with IV contrast Usually Not Appropriate O
MRA head without and with IV contrast Usually Not Appropriate O
MRA head without IV contrast Usually Not Appropriate O
MRI head with IV contrast Usually Not Appropriate O
MRV head with IV contrast Usually Not Appropriate O
MRV head without and with IV contrast Usually Not Appropriate O
MRV head without IV contrast Usually Not Appropriate O
CT head with IV contrast Usually Not Appropriate ☢☢☢
CT head without and with IV contrast Usually Not Appropriate ☢☢☢
CT head without IV contrast Usually Not Appropriate ☢☢☢
CTA head with IV contrast Usually Not Appropriate ☢☢☢
CTV head with IV contrast Usually Not Appropriate ☢☢☢

Variant: 4   Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
Procedure Appropriateness Category Relative Radiation Level
MRI head without and with IV contrast Usually Appropriate O
MRI head without IV contrast Usually Appropriate O
CT head without IV contrast Usually Appropriate ☢☢☢
MRV head with IV contrast May Be Appropriate O
MRV head without and with IV contrast May Be Appropriate O
MRV head without IV contrast May Be Appropriate O
CTV head with IV contrast May Be Appropriate ☢☢☢
Arteriography cervicocerebral Usually Not Appropriate ☢☢☢
MRA head with IV contrast Usually Not Appropriate O
MRA head without and with IV contrast Usually Not Appropriate O
MRA head without IV contrast Usually Not Appropriate O
MRI head with IV contrast Usually Not Appropriate O
CT head with IV contrast Usually Not Appropriate ☢☢☢
CT head without and with IV contrast Usually Not Appropriate ☢☢☢
CTA head with IV contrast Usually Not Appropriate ☢☢☢

Variant: 5   Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
Procedure Appropriateness Category Relative Radiation Level
MRI head without and with IV contrast Usually Appropriate O
MRI thoracic spine with IV contrast May Be Appropriate (Disagreement) O
MRI thoracic spine without and with IV contrast May Be Appropriate O
MRI thoracic spine without IV contrast May Be Appropriate O
Arteriography cervicocerebral Usually Not Appropriate ☢☢☢
MRA head with IV contrast Usually Not Appropriate O
MRA head without and with IV contrast Usually Not Appropriate O
MRA head without IV contrast Usually Not Appropriate O
MRI head with IV contrast Usually Not Appropriate O
MRI head without IV contrast Usually Not Appropriate O
MRV head with IV contrast Usually Not Appropriate O
MRV head without and with IV contrast Usually Not Appropriate O
MRV head without IV contrast Usually Not Appropriate O
CT head with IV contrast Usually Not Appropriate ☢☢☢
CT head without and with IV contrast Usually Not Appropriate ☢☢☢
CT head without IV contrast Usually Not Appropriate ☢☢☢
CTA head with IV contrast Usually Not Appropriate ☢☢☢
CTV head with IV contrast Usually Not Appropriate ☢☢☢

Variant: 6   Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
Procedure Appropriateness Category Relative Radiation Level
MRI head without IV contrast Usually Appropriate O
CT head without IV contrast Usually Appropriate ☢☢☢
MRV head without IV contrast May Be Appropriate O
CTV head with IV contrast May Be Appropriate ☢☢☢
Arteriography cervicocerebral Usually Not Appropriate ☢☢☢
MRA head with IV contrast Usually Not Appropriate O
MRA head without and with IV contrast Usually Not Appropriate O
MRA head without IV contrast Usually Not Appropriate O
MRI head with IV contrast Usually Not Appropriate O
MRI head without and with IV contrast Usually Not Appropriate O
MRV head with IV contrast Usually Not Appropriate O
MRV head without and with IV contrast Usually Not Appropriate O
CT head with IV contrast Usually Not Appropriate ☢☢☢
CT head without and with IV contrast Usually Not Appropriate ☢☢☢
CTA head with IV contrast Usually Not Appropriate ☢☢☢

Variant: 7   Headache with one or more of the following “red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
Procedure Appropriateness Category Relative Radiation Level
MRI head without and with IV contrast Usually Appropriate O
MRI head without IV contrast Usually Appropriate O
CT head without IV contrast Usually Appropriate ☢☢☢
Arteriography cervicocerebral Usually Not Appropriate ☢☢☢
MRA head with IV contrast Usually Not Appropriate O
MRA head without and with IV contrast Usually Not Appropriate O
MRA head without IV contrast Usually Not Appropriate O
MRI head with IV contrast Usually Not Appropriate O
MRV head with IV contrast Usually Not Appropriate O
MRV head without and with IV contrast Usually Not Appropriate O
MRV head without IV contrast Usually Not Appropriate O
CT head with IV contrast Usually Not Appropriate ☢☢☢
CT head without and with IV contrast Usually Not Appropriate ☢☢☢
CTA head with IV contrast Usually Not Appropriate ☢☢☢
CTV head with IV contrast Usually Not Appropriate ☢☢☢

Variant: 8   Headache without any of the following “red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
Procedure Appropriateness Category Relative Radiation Level
Arteriography cervicocerebral Usually Not Appropriate ☢☢☢
MRA head with IV contrast Usually Not Appropriate O
MRA head without and with IV contrast Usually Not Appropriate O
MRA head without IV contrast Usually Not Appropriate O
MRI head with IV contrast Usually Not Appropriate O
MRI head without and with IV contrast Usually Not Appropriate O
MRI head without IV contrast Usually Not Appropriate O
MRV head with IV contrast Usually Not Appropriate O
MRV head without and with IV contrast Usually Not Appropriate O
MRV head without IV contrast Usually Not Appropriate O
CT head with IV contrast Usually Not Appropriate ☢☢☢
CT head without and with IV contrast Usually Not Appropriate ☢☢☢
CT head without IV contrast Usually Not Appropriate ☢☢☢
CTA head with IV contrast Usually Not Appropriate ☢☢☢
CTV head with IV contrast Usually Not Appropriate ☢☢☢

Panel Members
Pallavi S. Utukuri, MDa; Robert Y. Shih, MDb; Amna A. Ajam, MD, MBBSc; Kathryn E. Callahan, MD, MSd; Doris Chen, MDe; Jeffrey W. Dunkle, MDf; Christopher H. Hunt, MDg; Jana Ivanidze, MDh; Luke N. Ledbetter, MDi; Ryan K. Lee, j; Omojo Malu, MDk; Jeffrey S. Pannell, MDl; Jeffrey M. Pollock, MDm; Sonja X. Potrebic, MDn; Michael Setzen, MDo; Richard D. Shih, MDp; Bruno P. Soares, MDq; Michael D. Staudt, MD, MScr; Lily L. Wang, MBBS, MPHs; Judah Burns, MDt.
Summary of Literature Review
Introduction/Background
Initial Imaging Definition

Initial imaging is defined as imaging at the beginning of the care episode for the medical condition defined by the variant. More than one procedure can be considered usually appropriate in the initial imaging evaluation when:

  • There are procedures that are equivalent alternatives (i.e., only one procedure will be ordered to provide the clinical information to effectively manage the patient’s care)

OR

  • There are complementary procedures (i.e., more than one procedure is ordered as a set or simultaneously wherein each procedure provides unique clinical information to effectively manage the patient’s care).
Discussion of Procedures by Variant
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
A. Arteriography cervicocerebral
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
B. CT head with IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
C. CT head without and with IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
D. CT head without IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
E. CTA head with IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
F. CTV head with IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
G. MRA head with IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
H. MRA head without and with IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
I. MRA head without IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
J. MRI head with IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
K. MRI head without and with IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
L. MRI head without IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
M. MRV head with IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
N. MRV head without and with IV contrast
Variant 1: Sudden onset severe headache that reaches maximal severity within one hour. Initial imaging.
O. MRV head without IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
A. Arteriography cervicocerebral
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
B. CT head with IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
C. CT head without and with IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
D. CT head without IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
E. CTA head with IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
F. CTV head with IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
G. MRA head with IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
H. MRA head without and with IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
I. MRA head without IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
J. MRI head with IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
K. MRI head without and with IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
L. MRI head without IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
M. MRV head with IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
N. MRV head without and with IV contrast
Variant 2: Primary migraine or tension-type headache. Normal neurologic examination. Initial imaging.
O. MRV head without IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
A. Arteriography cervicocerebral
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
B. CT head with IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
C. CT head without and with IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
D. CT head without IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
E. CTA head with IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
F. CTV head with IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
G. MRA head with IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
H. MRA head without and with IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
I. MRA head without IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
J. MRI head with IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
K. MRI head without and with IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
L. MRI head without IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
M. MRV head with IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
N. MRV head without and with IV contrast
Variant 3: Primary trigeminal autonomic cephalalgias (eg, cluster headache). Initial imaging.
O. MRV head without IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
A. Arteriography cervicocerebral
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
B. CT head with IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
C. CT head without and with IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
D. CT head without IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
E. CTA head with IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
F. CTV head with IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
G. MRA head with IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
H. MRA head without and with IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
I. MRA head without IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
J. MRI head with IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
K. MRI head without and with IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
L. MRI head without IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
M. MRV head with IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
N. MRV head without and with IV contrast
Variant 4: Headache with features of intracranial hypertension (eg, papilledema, pulsatile tinnitus, visual symptoms worse on Valsalva). Initial imaging.
O. MRV head without IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
A. Arteriography cervicocerebral
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
B. CT head with IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
C. CT head without and with IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
D. CT head without IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
E. CTA head with IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
F. CTV head with IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
G. MRA head with IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
H. MRA head without and with IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
I. MRA head without IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
J. MRI head with IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
K. MRI head without and with IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
L. MRI head without IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
M. MRI thoracic spine with IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
N. MRI thoracic spine without and with IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
O. MRI thoracic spine without IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
P. MRV head with IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
Q. MRV head without and with IV contrast
Variant 5: Headache with features of intracranial hypotension (eg, positional, worse when upright, better when lying down). Initial imaging.
R. MRV head without IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
A. Arteriography cervicocerebral
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
B. CT head with IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
C. CT head without and with IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
D. CT head without IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
E. CTA head with IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
F. CTV head with IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
G. MRA head with IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
H. MRA head without and with IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
I. MRA head without IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
J. MRI head with IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
K. MRI head without and with IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
L. MRI head without IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
M. MRV head with IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
N. MRV head without and with IV contrast
Variant 6: Headache with new onset or pattern during pregnancy or peripartum period. Initial imaging.
O. MRV head without IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
A. Arteriography cervicocerebral
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
B. CT head with IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
C. CT head without and with IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
D. CT head without IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
E. CTA head with IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
F. CTV head with IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
G. MRA head with IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
H. MRA head without and with IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
I. MRA head without IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
J. MRI head with IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
K. MRI head without and with IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
L. MRI head without IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
M. MRV head with IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
N. MRV head without and with IV contrast
Variant 7: Headache with one or more of the following "red flags”: increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (>50 years) of onset, or posttraumatic onset. Initial imaging.
O. MRV head without IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
A. Arteriography cervicocerebral
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
B. CT head with IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
C. CT head without and with IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
D. CT head without IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
E. CTA head with IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
F. CTV head with IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
G. MRA head with IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
H. MRA head without and with IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
I. MRA head without IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
J. MRI head with IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
K. MRI head without and with IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
L. MRI head without IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
M. MRV head with IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
N. MRV head without and with IV contrast
Variant 8: Headache without any of the following "red flags”: sudden onset ("thunderclap"), features of intracranial hypertension or hypotension, new onset or pattern during pregnancy or peripartum period, increasing frequency or severity, fever or neurologic deficit, history of cancer or immunocompromise, older age (greater than 50 years of age) of onset, or post-traumatic onset. Initial imaging.
O. MRV head without IV contrast
Summary of Highlights
Supporting Documents

The evidence table, literature search, and appendix for this topic are available at https://acsearch.acr.org/list. The appendix includes the strength of evidence assessment and the final rating round tabulations for each recommendation.

For additional information on the Appropriateness Criteria methodology and other supporting documents, please go to the ACR website at https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Appropriateness-Criteria.

Safety Considerations in Pregnant Patients

Imaging of the pregnant patient can be challenging, particularly with respect to minimizing radiation exposure and risk. For further information and guidance, see the following ACR documents:

·        ACR–SPR Practice Parameter for the Safe and Optimal Performance of Fetal Magnetic Resonance Imaging (MRI)

·        ACR-SPR Practice Parameter for Imaging Pregnant or Potentially Pregnant Patients with Ionizing Radiation

·        ACR-ACOG-AIUM-SMFM-SRU Practice Parameter for the Performance of Standard Diagnostic Obstetrical Ultrasound

·        ACR Manual on Contrast Media

·        ACR Manual on MR Safety

Appropriateness Category Names and Definitions

Appropriateness Category Name

Appropriateness Rating

Appropriateness Category Definition

Usually Appropriate

7, 8, or 9

The imaging procedure or treatment is indicated in the specified clinical scenarios at a favorable risk-benefit ratio for patients.

May Be Appropriate

4, 5, or 6

The imaging procedure or treatment may be indicated in the specified clinical scenarios as an alternative to imaging procedures or treatments with a more favorable risk-benefit ratio, or the risk-benefit ratio for patients is equivocal.

May Be Appropriate (Disagreement)

5

The individual ratings are too dispersed from the panel median. The different label provides transparency regarding the panel’s recommendation. “May be appropriate” is the rating category and a rating of 5 is assigned.

Usually Not Appropriate

1, 2, or 3

The imaging procedure or treatment is unlikely to be indicated in the specified clinical scenarios, or the risk-benefit ratio for patients is likely to be unfavorable.

Relative Radiation Level Information

Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level (RRL) indication has been included for each imaging examination. The RRLs are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure. Patients in the pediatric age group are at inherently higher risk from exposure, because of both organ sensitivity and longer life expectancy (relevant to the long latency that appears to accompany radiation exposure). For these reasons, the RRL dose estimate ranges for pediatric examinations are lower as compared with those specified for adults (see Table below). Additional information regarding radiation dose assessment for imaging examinations can be found in the ACR Appropriateness Criteria® Radiation Dose Assessment Introduction document.

Relative Radiation Level Designations

Relative Radiation Level*

Adult Effective Dose Estimate Range

Pediatric Effective Dose Estimate Range

O

0 mSv

 0 mSv

<0.1 mSv

<0.03 mSv

☢☢

0.1-1 mSv

0.03-0.3 mSv

☢☢☢

1-10 mSv

0.3-3 mSv

☢☢☢☢

10-30 mSv

3-10 mSv

☢☢☢☢☢

30-100 mSv

10-30 mSv

*RRL assignments for some of the examinations cannot be made, because the actual patient doses in these procedures vary as a function of a number of factors (e.g., region of the body exposed to ionizing radiation, the imaging guidance that is used). The RRLs for these examinations are designated as “Varies.”

References
1. Jordan JE, Flanders AE. Headache and Neuroimaging: Why We Continue to Do It. [Review]. AJNR Am J Neuroradiol. 41(7):1149-1155, 2020 07.
2. Gadde JA, Cantrell S, Patel SS, Mullins ME. Neuroimaging of Adults with Headache: Appropriateness, Utilization, and an Economical Overview. [Review]. Neuroimaging Clin N Am. 29(2):203-211, 2019 May.
3. Kuruvilla DE, Lipton RB. Appropriate use of neuroimaging in headache. [Review]. Curr Pain Headache Rep. 19(6):17, 2015 Jun.
4. Gilbert JW, Johnson KM, Larkin GL, Moore CL. Atraumatic headache in US emergency departments: recent trends in CT/MRI utilisation and factors associated with severe intracranial pathology. Emerg Med J. 2011.
5. Nesselroth D, Klang E, Soffer S, et al. Yield of head CT for acute findings in patients presenting to the emergency department. Clin Imaging. 73:1-5, 2021 May.
6. Salmela MB, Mortazavi S, Jagadeesan BD, et al. ACR Appropriateness Criteria® Cerebrovascular Disease. J Am Coll Radiol 2017;14:S34-S61.
7. Policeni B, Corey AS, Burns J, et al. ACR Appropriateness Criteria® Cranial Neuropathy. J Am Coll Radiol 2017;14:S406-S20.
8. Expert Panel on Neurologic Imaging:, Kirsch CFE, Bykowski J, et al. ACR Appropriateness Criteria R Sinonasal Disease. J. Am. Coll. Radiol.. 14(11S):S550-S559, 2017 Nov.
9. Shih RY, Burns J, Ajam AA, et al. ACR Appropriateness Criteria® Head Trauma: 2021 Update. J Am Coll Radiol 2021;18:S13-S36.
10. Long D, Koyfman A, Long B. The Thunderclap Headache: Approach and Management in the Emergency Department. [Review]. J Emerg Med. 56(6):633-641, 2019 Jun.
11. Malhotra A, Wu X, Gandhi D, Sanelli P. The Patient with Thunderclap Headache. [Review]. Neuroimaging Clin N Am. 28(3):335-351, 2018 Aug.
12. Arrigan MT, Heran MKS, Shewchuk JR. Reversible cerebral vasoconstriction syndrome: an important and common cause of thunderclap and recurrent headaches. [Review]. Clin Radiol. 73(5):417-427, 2018 05.
13. Mortimer AM, Bradley MD, Stoodley NG, Renowden SA. Thunderclap headache: diagnostic considerations and neuroimaging features. [Review]. Clin Radiol. 68(3):e101-13, 2013 Mar.
14. Kwon R. Calculated Decisions: Ottawa Subarachnoid Hemorrhage Rule. Emerg. med. pract.. 21(2):CD1-2, 2019 Feb 01.
15. Godwin SA, Cherkas DS, Panagos PD, Shih RD, Byyny R, Wolf SJ. Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Acute Headache. Annals of Emergency Medicine. 74(4):e41-e74, 2019 10.
16. Blok KM, Rinkel GJ, Majoie CB, et al. CT within 6 hours of headache onset to rule out subarachnoid hemorrhage in nonacademic hospitals. Neurology. 84(19):1927-32, 2015 May 12.
17. Dubosh NM, Bellolio MF, Rabinstein AA, Edlow JA. Sensitivity of Early Brain Computed Tomography to Exclude Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis. [Review]. Stroke. 47(3):750-5, 2016 Mar.
18. Alons IME, Goudsmit BFJ, Jellema K, van Walderveen MAA, Wermer MJH, Algra A. Yield of Computed Tomography (CT) Angiography in Patients with Acute Headache, Normal Neurological Examination, and Normal Non Contrast CT: A Meta-Analysis. [Review]. J STROKE CEREBROVASC DIS. 27(4):1077-1084, 2018 Apr.
19. da Rocha AJ, da Silva CJ, Gama HP, et al. Comparison of magnetic resonance imaging sequences with computed tomography to detect low-grade subarachnoid hemorrhage: Role of fluid-attenuated inversion recovery sequence. Journal of Computer Assisted Tomography. 30(2):295-303, 2006 Mar-Apr.J Comput Assist Tomogr. 30(2):295-303, 2006 Mar-Apr.
20. Ashraf R, Akhtar M, Akhtar S, Manzoor I. Diagnostic accuracy of flair in detection of acute subarachnoid hemorrhage in patients presenting with severe headache. J Neuroradiol. 46(5):294-298, 2019 Sep.
21. Honningsvag LM, Hagen K, Haberg A, Stovner LJ, Linde M. Intracranial abnormalities and headache: A population-based imaging study (HUNT MRI). Cephalalgia. 36(2):113-21, 2016 Feb.
22. GBD Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1211-59.
23. . Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 38(1):1-211, 2018 01.
24. Vijiaratnam N, Barber D, Lim KZ, et al. Migraine: Does aura require investigation?. Clinical Neurology & Neurosurgery. 148:110-4, 2016 Sep.Clin Neurol Neurosurg. 148:110-4, 2016 Sep.
25. Wang R, Liu R, Dong Z, et al. Unnecessary Neuroimaging for Patients With Primary Headaches. Headache. 59(1):63-68, 2019 01.
26. Sempere AP, Porta-Etessam J, Medrano V, et al. Neuroimaging in the evaluation of patients with non-acute headache. Cephalalgia. 2005; 25(1):30-35.
27. Russo A, Silvestro M, Tessitore A, Tedeschi G. Advances in migraine neuroimaging and clinical utility: from the MRI to the bedside. [Review]. Expert rev. neurotherapeutics. 18(7):533-544, 2018 07.
28. Wolf ME, Okazaki S, Eisele P, et al. Arterial Spin Labeling Cerebral Perfusion Magnetic Resonance Imaging in Migraine Aura: An Observational Study. J STROKE CEREBROVASC DIS. 27(5):1262-1266, 2018 May.
29. Ferraro S, Nigri A, Bruzzone MG, et al. Cluster headache: insights from resting-state functional magnetic resonance imaging. [Review]. Neurol Sci. 40(Suppl 1):45-47, 2019 May.
30. Burish M. Cluster Headache and Other Trigeminal Autonomic Cephalalgias. [Review]. Continuum. 24(4, Headache):1137-1156, 2018 08.
31. Favier I, van Vliet JA, Roon KI, et al. Trigeminal autonomic cephalgias due to structural lesions: a review of 31 cases. Arch Neurol. 2007;64(1):25-31.
32. Goadsby PJ. Trigeminal autonomic cephalalgias. Continuum (Minneap Minn) 2012;18:883-95.
33. de Coo IF, Wilbrink LA, Haan J. Symptomatic Trigeminal Autonomic Cephalalgias. [Review]. Curr Pain Headache Rep. 19(8):39, 2015 Aug.
34. Mitsikostas DD, Ashina M, Craven A, et al. European Headache Federation consensus on technical investigation for primary headache disorders. J HEADACHE PAIN. 17:5, 2015.
35. Maralani PJ, Hassanlou M, Torres C, et al. Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension. Clin Radiol. 67(7):656-63, 2012 Jul.
36. Hoffmann J, Mollan SP, Paemeleire K, Lampl C, Jensen RH, Sinclair AJ. European headache federation guideline on idiopathic intracranial hypertension. J HEADACHE PAIN. 19(1):93, 2018 Oct 08.
37. Sobri M, Lamont AC, Alias NA, Win MN. Red flags in patients presenting with headache: clinical indications for neuroimaging. Br J Radiol 2003;76:532-5.
38. Hoffmann J, Huppertz HJ, Schmidt C, et al. Morphometric and volumetric MRI changes in idiopathic intracranial hypertension. Cephalalgia. 33(13):1075-84, 2013 Oct.
39. Sparaco M, Feleppa M, Bigal ME. Cerebral Venous Thrombosis and Headache--A Case-Series. Headache. 55(6):806-14, 2015 Jun.
40. Friedman DI. Headaches in Idiopathic Intracranial Hypertension. [Review]. J Neuroophthalmol. 39(1):82-93, 2019 03.
41. Dinia L, Bonzano L, Albano B, et al. White matter lesions progression in migraine with aura: a clinical and MRI longitudinal study. Journal of Neuroimaging. 23(1):47-52, 2013 Jan.
42. Reis DJ. Brain-stem mechanisms governing resting and reflex tone of precapillary vessels. J Cardiovasc Pharmacol 1985;7 Suppl 3:S160-6.
43. Bond KM, Benson JC, Cutsforth-Gregory JK, Kim DK, Diehn FE, Carr CM. Spontaneous Intracranial Hypotension: Atypical Radiologic Appearances, Imaging Mimickers, and Clinical Look-Alikes. [Review]. AJNR Am J Neuroradiol. 41(8):1339-1347, 2020 08.
44. Perez-Vega C, Robles-Lomelin P, Robles-Lomelin I, Garcia Navarro V. Spontaneous intracranial hypotension: key features for a frequently misdiagnosed disorder. [Review]. Neurological Sciences. 41(9):2433-2441, 2020 Sep.
45. Amrhein TJ, Kranz PG. Spontaneous Intracranial Hypotension: Imaging in Diagnosis and Treatment. [Review]. Radiologic Clinics of North America. 57(2):439-451, 2019 Mar.
46. Kim BR, Lee JW, Lee E, Kang Y, Ahn JM, Kang HS. Utility of heavily T2-weighted MR myelography as the first step in CSF leak detection and the planning of epidural blood patches. Journal of Clinical Neuroscience. 77:110-115, 2020 Jul.
47. Robbins MS, Farmakidis C, Dayal AK, Lipton RB. Acute headache diagnosis in pregnant women: a hospital-based study. Neurology. 85(12):1024-30, 2015 Sep 22.
48. Raffaelli B, Neeb L, Israel-Willner H, et al. Brain imaging in pregnant women with acute headache. J Neurol. 265(8):1836-1843, 2018 Aug.
49. Shobeiri E, Torabinejad B. Brain magnetic resonance imaging findings in postpartum headache. Neuroradiol. j.. 32(1):4-9, 2019 Feb.
50. Molina-Botello D, Rodriguez-Sanchez JR, Cuevas-Garcia J, et al. Pregnancy and brain tumors; a systematic review of the literature. J Clin Neurosci. 86:211-216, 2021 Apr.
51. Negro A, Delaruelle Z, Ivanova TA, et al. Headache and pregnancy: a systematic review. [Review]. J HEADACHE PAIN. 18(1):106, 2017 Oct 19.
52. Robbins MS. Headache in Pregnancy. [Review]. Continuum. 24(4, Headache):1092-1107, 2018 08.
53. Kernick DP, Ahmed F, Bahra A, et al. Imaging patients with suspected brain tumour: guidance for primary care. Br J Gen Pract. 2008;58(557):880-885.
54. Clarke CE, Edwards J, Nicholl DJ, Sivaguru A. Imaging results in a consecutive series of 530 new patients in the Birmingham Headache Service. Journal of Neurology. 257(8):1274-8, 2010 Aug.J Neurol. 257(8):1274-8, 2010 Aug.
55. Do TP, Remmers A, Schytz HW, et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. [Review]. Neurology. 92(3):134-144, 2019 01 15.
56. Holle D, Obermann M. The role of neuroimaging in the diagnosis of headache disorders. Therapeutic Advances in Neurological Disorders. 6(6):369-74, 2013 Nov.Ther. adv. neurol. disord.. 6(6):369-74, 2013 Nov.
57. Mehta A, Danesh J, Kuruvilla D. Cerebral Venous Thrombosis Headache. [Review]. Curr Pain Headache Rep. 23(7):47, 2019 May 30.
58. Gaughran CG, Tubridy N. Headaches, neurologists and the emergency department. Ir Med J. 107(6):168-71, 2014 Jun.
59. Eller M, Goadsby PJ. MRI in headache. [Review]. Expert rev. neurotherapeutics. 13(3):263-73, 2013 Mar.
60. Wang HZ, Simonson TM, Greco WR, Yuh WT. Brain MR imaging in the evaluation of chronic headache in patients without other neurologic symptoms. Acad Radiol 2001;8:405-8.
61. Choosing Wisely® An initiative of the ABIM Foundation. American College of Radiology. Five Things Physicians and Patients Should Question.  Available at: http://www.choosingwisely.org/societies/american-college-of-radiology/.
62. Goldstein L, Laytman T, Steiner I. Is Head Computerized Tomography Indicated for the Workup of Headache in Patients with Intact Neurological Examination. Eur Neurol. 80(5-6):341-344, 2018.
63. American College of Radiology. ACR–SPR Practice Parameter for the Safe and Optimal Performance of Fetal Magnetic Resonance Imaging (MRI). Available at: https://gravitas.acr.org/PPTS/GetDocumentView?docId=89+&releaseId=2.
64. American College of Radiology. ACR-SPR Practice Parameter for Imaging Pregnant or Potentially Pregnant Patients with Ionizing Radiation.  Available at: https://gravitas.acr.org/PPTS/GetDocumentView?docId=23+&releaseId=2.
65. American College of Radiology. ACR-ACOG-AIUM-SMFM-SRU Practice Parameter for the Performance of Standard Diagnostic Obstetrical Ultrasound. Available at: https://gravitas.acr.org/PPTS/GetDocumentView?docId=28+&releaseId=2.
66. American College of Radiology. ACR Committee on Drugs and Contrast Media. Manual on Contrast Media.  Available at: https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Contrast-Manual.
67. American College of Radiology. ACR Committee on MR Safety. 2024 ACR Manual on MR Safety.  Available at: https://edge.sitecorecloud.io/americancoldf5f-acrorgf92a-productioncb02-3650/media/ACR/Files/Clinical/Radiology-Safety/Manual-on-MR-Safety.pdf.
68. American College of Radiology. ACR Appropriateness Criteria® Radiation Dose Assessment Introduction. Available at: https://edge.sitecorecloud.io/americancoldf5f-acrorgf92a-productioncb02-3650/media/ACR/Files/Clinical/Appropriateness-Criteria/ACR-Appropriateness-Criteria-Radiation-Dose-Assessment-Introduction.pdf.
Disclaimer

The ACR Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient’s clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient’s condition are ranked.  Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the FDA have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination.